Efficacy Evaluation of 10-Hydroxy Chondrofoline and Tafenoquine against Leishmania tropica (HTD(7))

Leishmaniasis is affirmed as a category one disease (most emerging and unmanageable) by the World Health Organization (WHO), affecting 98 countries with an annual global incidence of ~1.2 million cases. Options for chemotherapeutic treatment are limited due to drug resistance and cytotoxicity. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sayyed Ibrahim, Nasir, Fazli, Malik, Nadia Shamshad, Alamzeb, Muhammad, Abbas, Muhammad, Rehman, Inayat Ur, Khuda, Fazli, Shah, Yasir, Goh, Khang Weh, Zeb, Alam, Ming, Long Chiau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415556/
https://www.ncbi.nlm.nih.gov/pubmed/36015153
http://dx.doi.org/10.3390/ph15081005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415556/
https://www.ncbi.nlm.nih.gov/pubmed/36015153
http://dx.doi.org/10.3390/ph15081005

Ejemplares similares